To read last Friday’s edition of Five things for pharma marketers to know, click here.

President Donald Trump has talked about the burden of health care costs since his first campaign, but he has signaled that his administration’s regulators are less inclined than his predecessor’s to ...

Voters rank lowering health care costs as a top priority, above housing, jobs, immigration, and crime, according to a September poll by Hart Research Associates for Families USA, a consumer health ...

Listen to the morning keynote session with Reddit's Jess Calef from the 2025 MM+M Media Summit. The pair underscore why the ...

Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or ...

Even before the political shift, that attitude was reflected at doctors’ offices as well. A 2023 study found that one-third ...

To read yesterday’s edition of Five things for pharma marketers to know, click here.

Trump to announce Lilly, Novo drug pricing deals; FDA approved a pricey drug over reviewer concerns; Novo’s new obesity pill.

Metsera-Pfizer-Novo updates; Why the FDA drug chief resigned; The “big flaw” in Big Pharma’s patient advocacy.

Vought has exerted extraordinary control over government spending this year, usurping congressional decisions on how the nation’s money is used.

Sanofi is rolling out a new global campaign that features the stories of six real patients, to underscore its core purpose.

Among applications and summaries publicly shared by states, themes include workforce development, telehealth, and access to healthy food.